bioRxivCancer Biology
High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer
S. Salcher, G. Sturm, L. Horvath, G. Untergasser, G. Fotakis, E. Panizzolo, A. Martowicz, G. Pall, G. Gamerith, M. Sykora, F. Augustin, K. Schmitz, F. Finotello, D. Rieder, S. Sopper, D. Wolf, A. Pircher, Z. Trajanoski
Abstract
Non-small cell lung cancer (NSCLC) is characterized by molecular heterogeneity with diverse immune cell infiltration patterns, which has been linked to both, therapy sensitivity and resistance. However, full understanding of how immune cell phenotypes vary across different patient and tumor subgroups is lacking. Here, we dissect the NSCLC tumor microenvironment at high resolution by integrating 1,212,463 single-cells from 538 samples and 309 patients across 29 datasets, including our own dataset capturing cells with low mRNA content. Based on the cellular composition we stratified patients into immune deserted, B cell, T cell, and myeloid cell subtypes. Using bulk samples with genomic and clinical information, we identified specific cellular components associated with tumor histology and genotypes. Analysis of cells with low mRNA content uncovered distinct subpopulations of tissue-resident neutrophils (TRNs) that acquire new functional properties in the tissue microenvironment, providing evidence for the plasticity of TRNs. TRN-derived gene signature was associated with anti-PD-L1 treatment failure in a large NSCLC cohort. In briefSalcher, Sturm, Horvath et al. integrate single-cell datasets to generate the largest transcriptome atlas in NSCLC, refining patient stratification based on tumor immune phenotypes, and revealing associations of histological subtypes and genotypes with specific cellular composition patterns. Coverage of cells with low mRNA content by single-cell sequencing identifies distinct tissue-resident neutrophil subpopulations, which acquire new properties within the tumor microenvironment. Gene signature from tissue-resident neutrophils is associated with immune checkpoint inhibitor treatment failure. The integrated atlas is publicly available online (https://luca.icbi.at), allowing the dissection of tumor-immune cell interactions in NSCLC. HighlightsO_LIHigh-resolution single-cell atlas of the tumor microenvironment (TME) in NSCLC. C_LIO_LIHistological tumor subtypes and driver genes imprint specific cellular TME patterns. C_LIO_LIscRNA-seq of cells with low transcript count identifies distinct tissue-resident neutrophil (TRN) subpopulations and non-canonical functional properties in the TME niche. C_LIO_LITRN gene signature identifies patients who are refractory to treatment with PD-L1 inhibitors. C_LI O_FIG O_LINKSMALLFIG WIDTH=199 HEIGHT=200 SRC="FIGDIR/small/491204v1_ufig1.gif" ALT="Figure 1"> View larger version (63K): org.highwire.dtl.DTLVardef@1050b6aorg.highwire.dtl.DTLVardef@3088c8org.highwire.dtl.DTLVardef@6408b8org.highwire.dtl.DTLVardef@1788c22_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single cell profiling reveals novel tumor and myeloid subpopulations in small cell lung cancer
J. M. Chan, A. Quintanal-Villalonga, … C. M. Rudin·bioRxiv·Dec 1, 2020
- Acquired resistance to anti-PD1 therapy in patients with NSCLC reveals changes in T cell phenotypes and MET amplification
S. Hiltbrunner, L. Cords, … A. Curioni-Fontecedro·bioRxiv·Apr 8, 2022
- Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
D. Memon, H. Rizvi, … M. D. Hellmann·bioRxiv·Jul 21, 2021
- Tumor-infiltrating natural killer cell profiling for therapeutic stratification in patients with resectable non-small cell lung cancer
Atsushi Ito, Sung Wook Kang, … Hyun-Sung Lee·Journal of Thoracic and Cardiovascular SurgeryPeer-reviewed·Mar 4, 2026
- Defining cellular determinants of resistance to PD-1 pathway blockade in non-small-cell lung cancer
Baolin Liu, Kaichao Feng, … Zemin Zhang·bioRxiv·Jun 6, 2024
- Small Cell Lung Cancer Neuroendocrine Subtypes are Associated with Different Immune Microenvironment and Checkpoint Molecule Distribution
D. Dora, C. Rivard, … Z. Lohinai·bioRxiv·Feb 2, 2020